Evaluate ALLN-177 in Patients With Enteric Hyperoxaluria
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Annamaria Kausz, MD MS
Allena Pharmaceuticals Inc
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
63 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alberta, Division of Urology
Edmonton, Alberta, Canada
- Silverado Research Inc
Victoria, British Columbia, Canada
- Toronto Digestive Disease Associates, Inc.
Vaughan, Ontario, Canada
- Centre de Recherche Du Centre Hospitalier de L'Université de Montréal (crchum)
Montreal, Quebec, Canada
- Research Center of Chu de Québec - Université Laval (chul)
Québec, Quebec, Canada
- Chu de Nancy-Hopital Brabois
Vandœuvre-lès-Nancy, France
- Charite Universitaetsmedizin Berlin
Berlin, Germany
- Universitaetsklinikum Bonn; Klinik Und Poliklinik Für Urologie Und Kinderurologie
Bonn, Germany
- Universitat Bonn - Zentrum Für Kinderheilkunde
Bonn, Germany
- Universitatsklinikum Freiburg, Klinik for Urologie
Freiburg im Breisgau, Germany
- Universitaetsklinikum Leipzig
Leipzig, Germany
- Pshi Gmbh; Pfützner Science & Health Institute Gmbh
Mainz, Germany
- Universitat Munchen - Großhadern
Munich, Germany
- Irccs Azienda Ospedaliera Universitaria San Martino Ist
Genova, Italy
- Asst Di Lecco
Lecco, Italy
- Azienda Socio-Sanitaria Territoriale Di Lecco (asst Di Lecco)
Lecco, Italy
- Fondazione Policlinico Universitario A. Gemelli - Universita Cattolica del Sacro Cuore
Rome, Italy
- Hospital Universitari de Girona Doctor Josep Trueta
Girona, Spain
- Complejo Asistencial de León
León, Spain
- Fundacion Jimenez Diaz
Madrid, Spain
- Hospital Universitario Infanta Sofia
Madrid, Spain
- Hospital Universitario Virgen del Rocio
Seville, Spain
- the Royal Free Hospital
London, United Kingdom
- Freeman Hospital
Newcastle upon Tyne, United Kingdom
- University of Alabama, Department of Urology
Birmingham, Alabama, United States
- Urology Centers of Alabama
Birmingham, Alabama, United States
- Mayo Clinic Hospital
Phoenix, Arizona, United States
- Urological Associates of Southern Arizona
Tucson, Arizona, United States
- Applied Research Center of Arkansas
Little Rock, Arkansas, United States
- Trovare Clinical Research
Bakersfield, California, United States
- Advanced Urology Institute
Daytona Beach, Florida, United States
- Mayo Clinic - Jacksonville
Jacksonville, Florida, United States
- Center for Advanced Gi (cfagi)
Maitland, Florida, United States
- South Medical Research Group, Inc.
Miami, Florida, United States
- North Idaho Urology
Coeur d'Alene, Idaho, United States
- Idaho Urologic Institue
Meridian, Idaho, United States
- Edmund J. Lewis and Associates
Chicago, Illinois, United States
- Iu Health Physicians
Indianapolis, Indiana, United States
- Regional Urology
Shreveport, Louisiana, United States
- Maine Nephrology Associates
Portland, Maine, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 May 2018
- Primary completion
- 30 Sept 2019
- Completion
- 28 Oct 2019
- Last update posted
- 27 Feb 2020
- Registered enrollment
- 115
- Registry id
- NCT03456830
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.